Geneos Wealth Management’s First Trust Large Cap Growth AlphaDEX Fund FTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
7,639
-86
-1% -$15.2K 0.03% 449
2026
Q1
$1.19M Sell
7,725
-150
-2% -$24.2K 0.03% 468
2025
Q4
$1.26M Sell
7,875
-116
-1% -$18.6K 0.03% 444
2025
Q3
$1.28M Sell
7,991
-332
-4% -$51.8K 0.03% 433
2025
Q2
$1.26M Buy
8,323
+3,539
+74% +$487K 0.03% 474
2025
Q1
$629K Sell
4,784
-40
-0.8% -$5.61K 0.02% 556
2024
Q4
$667K Sell
4,824
-90
-2% -$12.6K 0.02% 509
2024
Q3
$646K Buy
4,914
+152
+3% +$18.9K 0.02% 499
2024
Q2
$584K Buy
4,762
+130
+3% +$15.6K 0.03% 456
2024
Q1
$571K Sell
4,632
-423
-8% -$49.1K 0.03% 467
2023
Q4
$554K Sell
5,055
-61
-1% -$6.16K 0.03% 463
2023
Q3
$495K Buy
5,116
+360
+8% +$36.2K 0.03% 470
2023
Q2
$482K Buy
4,756
+61
+1% +$5.77K 0.03% 469
2023
Q1
$437K Buy
4,695
+201
+4% +$18.7K 0.03% 470
2022
Q4
$411K Buy
4,494
+838
+23% +$77.7K 0.02% 458
2022
Q3
$312K Sell
3,656
-1,595
-30% -$149K 0.02% 494
2022
Q2
$466K Sell
5,251
-593
-10% -$56.8K 0.02% 516
2022
Q1
$623K Buy
5,844
+125
+2% +$13.2K 0.03% 479
2021
Q4
$687K Buy
5,719
+2,593
+83% +$307K 0.03% 491
2021
Q3
$348K Buy
3,126
+10
+0.3% +$1.14K 0.01% 666
2021
Q2
$343K Hold
3,116
– – 0.01% 655
2021
Q1
$321K Hold
3,116
– – 0.01% 769
2020
Q4
$301K Buy
3,116
+40
+1% +$3.61K 0.01% 676
2020
Q3
$253K Sell
3,076
-1,093
-26% -$89.8K 0.01% 606
2020
Q2
$312K Sell
4,169
-9
-0.2% -$631 0.02% 534
2020
Q1
$247K Buy
4,178
+520
+14% +$36.7K 0.02% 550
2019
Q4
$267K Sell
3,658
-124
-3% -$8.78K 0.01% 593
2019
Q3
$262K Buy
3,782
+42
+1% +$2.98K 0.02% 567
2019
Q2
$263K Buy
3,740
+100
+3% +$6.82K 0.02% 581
2019
Q1
$243K Buy
3,640
+30
+0.8% +$1.9K 0.02% 581
2018
Q4
$204K Hold
3,610
– – 0.02% 596
2018
Q3
$254K Buy
3,610
+1,750
+94% +$120K 0.02% 562
2018
Q2
$122K Buy
1,860
+1,000
+116% +$65.7K 0.01% 717
2018
Q1
$54K Buy
860
+250
+41% +$16.1K ﹤0.01% 964
2017
Q4
$37K Sell
610
-163
-21% -$9.77K ﹤0.01% 1135
2017
Q3
$44K Hold
773
– – ﹤0.01% 1002
2017
Q2
$42K Buy
773
+27
+4% +$1.46K ﹤0.01% 993
2017
Q1
$39K Sell
746
-4
-0.5% -$206 ﹤0.01% 981
2016
Q4
$36K Hold
750
– – ﹤0.01% 953
2016
Q3
$37K Buy
750
+41
+6% +$2.08K 0.01% 919
2016
Q2
$35K Sell
709
-166
-19% -$8.07K 0.01% 923
2016
Q1
$42K Buy
+875
New +$40.1K 0.01% 845

Other funds holding FTC

Geneos Wealth Management's FTC Position: Q2 2026 in Review

Geneos Wealth Management reduced its First Trust Large Cap Growth AlphaDEX Fund (FTC) stake by 1.1% in Q2 2026, selling an estimated $15.2K and leaving 7,639 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #449.

Geneos Wealth Management first reported a position in FTC in Q1 2016 and has held it in 42 quarters since. 224 funds tracked by Wall St. Rank hold FTC as of Q2 2026.

  • Geneos Wealth Management held 7,639 shares of First Trust Large Cap Growth AlphaDEX Fund worth $1.48M as of Q2 2026.
  • Geneos Wealth Management sold 86 First Trust Large Cap Growth AlphaDEX Fund shares in Q2 2026, an estimated $15.2K.
  • First Trust Large Cap Growth AlphaDEX Fund made up 0.03% of Geneos Wealth Management's portfolio in Q2 2026, its #449 holding.
  • Geneos Wealth Management first reported a position in First Trust Large Cap Growth AlphaDEX Fund in Q1 2016 and has held it in 42 quarters since.
  • 224 funds tracked by Wall St. Rank held First Trust Large Cap Growth AlphaDEX Fund as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.